People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.
Wesana Health Announces Voting Results of AGSM | Psychedelic Invest
Wesana Health Holdings Inc. (CSE: WESA | OTCQB: WSNAF), a data-driven life sciences company, today announced that Wesana Health Inc., a subsidiary of the Company, has received an